| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.66B | 10.01B | 9.38B | 8.75B | 8.08B | 7.72B |
| Gross Profit | 4.43B | 4.43B | 4.30B | 4.03B | 3.57B | 3.39B |
| EBITDA | 1.85B | 1.93B | 1.76B | 1.59B | 1.34B | 1.25B |
| Net Income | 926.35M | 890.70M | 1.03B | 263.26M | 743.72M | 569.71M |
Balance Sheet | ||||||
| Total Assets | 12.55B | 13.87B | 12.19B | 11.35B | 11.33B | 9.28B |
| Cash, Cash Equivalents and Short-Term Investments | 1.08B | 1.12B | 1.11B | 2.43B | 2.60B | 653.60M |
| Total Debt | 3.88B | 4.93B | 3.80B | 3.40B | 4.08B | 5.02B |
| Total Liabilities | 6.95B | 7.66B | 6.60B | 6.33B | 6.28B | 7.16B |
| Stockholders Equity | 5.60B | 6.21B | 5.59B | 5.02B | 5.05B | 2.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -520.27M | -1.03B | 1.05B | 820.21M | 233.15M |
| Operating Cash Flow | 0.00 | 1.50B | 1.32B | 1.74B | 1.28B | 816.81M |
| Investing Cash Flow | 0.00 | -1.94B | -2.30B | -634.61M | -444.46M | -481.72M |
| Financing Cash Flow | 0.00 | 448.42M | -349.99M | -1.25B | 1.11B | -379.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥201.22B | 22.33 | 11.00% | 2.20% | 6.75% | -0.16% | |
73 Outperform | ¥25.83B | 8.53 | ― | 2.62% | -14.20% | 231.20% | |
72 Outperform | ¥421.05B | 24.29 | ― | 1.30% | 9.57% | 9.73% | |
67 Neutral | ¥7.36B | 57.57 | ― | 1.36% | -4.59% | -14.60% | |
67 Neutral | ¥74.23B | 7.12 | ― | 2.77% | 0.41% | 25.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | ¥12.87B | 16.24 | ― | 2.40% | 6.65% | -12.53% |